Metro Minnesota Community Clinical Oncology Program — Saint Louis Park, Minnesota

Metro Minnesota Community Clinical Oncology Program is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Metro Minnesota Community Clinical Oncology Program has participated in 3 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Acrotech Biopharma Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Minnesota Community Clinical Oncology Program?

Metro Minnesota Community Clinical Oncology Program has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Minnesota Community Clinical Oncology Program conducted?

Metro Minnesota Community Clinical Oncology Program has 3 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is Metro Minnesota Community Clinical Oncology Program accredited by Crixeo Health?

Metro Minnesota Community Clinical Oncology Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro Minnesota Community Clinical Oncology Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.